Aromatase, breast cancer and obesity: a complex interaction. - Wikidata - awgldk - TriplyDB

Aromatase, breast cancer and obesity: a complex interaction.

Aromatase, breast cancer and obesity: a complex interaction.

http://www.wikidata.org/entity/Q36191587

about

Aromatase expression and regulation in breast and endometrial cancer Adipocytes: impact on tumor growth and potential sites for therapeutic intervention Enzymatic intracrine regulation of white adipose tissue Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery CYP19A1 promoter methylation in saliva associated with milestones of pubertal timing in urban girls Association of obesity and circulating adipose stromal cells among breast cancer survivors.Hypothalamic gene transfer of BDNF inhibits breast cancer progression and metastasis in middle age obese mice Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma.Obesity and cancer--mechanisms underlying tumour progression and recurrence n-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer.Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer.Sex, body mass index, and dietary fiber intake influence the human gut microbiome.Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.PPARγ agonists target aromatase via both PGE2 and BRCA1.Multiple roles of COUP-TFII in cancer initiation and progression Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index.Overexpression of G0/G1 Switch Gene 2 in Adipose Tissue of Transgenic Quail Inhibits Lipolysis Associated with Egg Laying.Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study.Weight change in adulthood and risk of postmenopausal breast cancer: the HUNT study of Norway.AMP-activated protein kinase and energy balance in breast cancer.Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis.The evolution of our understanding of endo-xenobiotic crosstalk and cytochrome P450 regulation and the therapeutic implications.The obesity-inflammation-eicosanoid axis in breast cancer.Sushi Domain-Containing Protein 3: A Potential Target for Breast Cancer.Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma Effects of Neonicotinoids on Promoter-Specific Expression and Activity of Aromatase (CYP19) in Human Adrenocortical Carcinoma (H295R) and Primary Umbilical Vein Endothelial (HUVEC) Cells.Postmenopausal Breast Cancer, Aromatase Inhibitors, and Bone Health: What the Surgeon Should Know.Obesity and Breast Cancer.Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients.Testosterone and secondary hypertension: new pieces to the puzzle.Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis.Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer.Aromatase inhibitors in obese breast cancer patients are not associated with increased plasma estradiol levels.

P2860

Q26749272-78280C9C-40D8-4C30-85C1-B6219BD0984E Q26830077-17676E80-9539-42C2-9961-62ECDB8FEAD9 Q26851926-4DC9644F-FAB3-4B7E-8ABA-59A49F70771D Q28069804-2B8CF874-863B-41F6-B52B-E32897683A79 Q29109882-177920F0-5D5A-4C35-86C4-800CB99D12E3 Q33591042-0A8727D5-BA7F-49C4-A228-9DE448571500 Q33870764-509F4FB0-436B-4D2B-8B0C-0F87F94B59DC Q34321877-8D9D6F24-B1CC-4473-9840-232A93C3C507 Q34404655-1CA7D39B-7A8C-4B82-9DE6-A7AD38598CB1 Q34425077-A5493CBE-B829-45BD-8C6E-5F2F319BE9E9 Q34577978-42EF9E3C-7B91-4D83-8F20-75F27E247F98 Q34695260-9FD41672-EB87-4E22-BCBC-BC6F40C36085 Q35432241-99638990-52DA-42BA-A4D4-E071E39DB36F Q35563195-CA7E39D0-27B2-4AD4-9E44-39B75175DA68 Q35809173-C063B1B5-8974-4C15-AC80-D4BC84B2F8A8 Q35873283-42FB1F03-2DEE-4AFC-8B93-9895ED21D5F3 Q36303977-F21427B9-711F-497C-9B32-71E6D300D37A Q36312989-9578DB89-B9CB-4EE2-B0B8-10D811E4EFE0 Q36419177-39898CB2-6C0B-4CA6-8B91-FEDB35DB3CAF Q36743714-3FC9D845-A84D-47FB-9F0B-826E6E5996FF Q36959883-1F144102-02C2-425C-B30F-6673A24ED9FE Q37018080-33055056-F4A1-4C4E-B529-E5ECCB87A81A Q37185735-97F0055F-DDF7-4051-B745-7E5598171E09 Q37685196-6A630881-8CA9-4FF4-A83D-5336E5F1F06E Q38062392-E9D86ABF-88CB-467B-B68F-559298C35C0E Q38128592-F1B1F834-C7F7-4AF8-AF5C-5E1E4DFAEEA8 Q38156366-B69E2222-C6BA-4BC4-86B7-660DF4B029DE Q38306311-4F74711E-F28A-4ACE-AF43-1F2A76593614 Q38381450-96A050C7-94C5-4985-A21C-13BFD5A20ABF Q38538492-9384DD0F-0312-4252-A279-DA0532D39B01 Q38598392-4D410243-A550-4218-9087-C0B378DFA072 Q38828135-87D078D7-1313-43F2-B6CD-7E1FC71A6B26 Q38836713-E3D55B2C-41A2-43E4-9184-D9AEA5A649FA Q39026644-4E8E17B3-E6F6-4E92-B123-2AC259E9C74C Q39043672-ED113B1E-4596-43A8-87E0-B8ACC0CC776E Q41558055-CEC9BF0F-08EE-4166-B69E-768478BCA5A4 Q43171849-A324E11E-F1E5-435E-B283-AF94B89C2DB2 Q47239487-3290C97D-8774-4AD2-918C-D71B2CC61039 Q47567895-CBA75FFC-A177-4F9E-8FAF-360641D91181 Q48374983-F4ABB7D8-66A8-4E74-B8D8-10FD5CA6F8F5

P2860

Aromatase, breast cancer and obesity: a complex interaction.

http://www.wikidata.org/entity/Q36191587

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Aromatase, breast cancer and obesity: a complex interaction.

@ast

Aromatase, breast cancer and obesity: a complex interaction.

@en

type

label

Aromatase, breast cancer and obesity: a complex interaction.

@ast

Aromatase, breast cancer and obesity: a complex interaction.

@en

prefLabel

Aromatase, breast cancer and obesity: a complex interaction.

@ast

Aromatase, breast cancer and obesity: a complex interaction.

@en

P1433

Q36191587-8D79B7E1-8C77-4B2D-8780-D5DE2A5ADAC0

P1476

Q36191587-EED783E6-11DB-45D2-8434-8C523C9312C0

P2093

Q36191587-779AD5FA-3E82-42C9-A50E-937E03FFC0E4

Q36191587-9A741914-8333-4B2A-BEB9-D876123ADEB8

Q36191587-A05CDD9B-F5A3-4FD9-A9F7-A12A0CD68BC9

Q36191587-C053893E-5DD0-47C4-B893-606464FAE5DC

Q36191587-C69A1337-ABA4-424F-B089-D59E2EF7E4B9

P2860

Q36191587-009F8AA3-4B5F-4617-B191-19E3C6A0BA23

Q36191587-0709D186-74CF-48BA-B3A6-5B48CC96A7E5

Q36191587-1724BA10-1A15-40C8-B422-93663529E683

Q36191587-1DA8150E-14F1-4591-BF2F-D178230C29D8

Q36191587-1E9FBB56-3BA9-4485-A3EE-6B292BBE6632

Q36191587-277A845C-CB28-4146-96F3-9D54DD2CB47C

Q36191587-2A76206B-DBC9-4265-A1F2-688932B552B2

Q36191587-2B4B732D-59A1-45BE-A7B3-92AF2EC464EA

Q36191587-2D3A5D5A-553C-43EF-BA1A-587704B2175B

Q36191587-2E85078A-B672-4501-B53C-1889A6E777D2

P304

Q36191587-5A06C965-4109-4BBD-AE7A-6CB69A41B619

P31

Q36191587-ED858BC8-566B-4DC0-8374-DD356AAF4D40

P356

Q36191587-4DC0EBD5-4899-4F1B-B70E-268397FF73AE

P433

Q36191587-881A3F77-0826-4C7C-B6F2-35EBD85D18D7

P478

Q36191587-72C82C85-B73D-4EB9-99D8-5F90C1F7AB71

P577

Q36191587-A4488E9F-CBA9-4627-83CC-FAF358E35B3A

P5875

Q36191587-A3E61CC2-C011-4565-B14A-4501569467C7

P698

Q36191587-E25D47B4-C913-4762-8A87-261574F75166

P921

Q36191587-B3ADB53A-E9DF-4040-A986-FC2C2107EA26

P932

Q36191587-6FE15C11-BEDA-4D97-BF83-531CBD9CC760

P356

J.TEM.2011.10.003

P1433

Trends in Endocrinology and Metabolism

P1476

Aromatase, breast cancer and obesity: a complex interaction.

@en

P2093

David C Brooks

http://www.w3.org/2001/XMLSchema#string

Dong Chen

http://www.w3.org/2001/XMLSchema#string

Hong Zhao

http://www.w3.org/2001/XMLSchema#string

Irene Moy

http://www.w3.org/2001/XMLSchema#string

Serdar E Bulun

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1

Sources of estrogen and their importance

International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes

Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2)

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

Prevalence and trends in obesity among US adults, 1999-2008

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

To block estrogen's synthesis or action: that is the question.

IKKbeta mediates cell shape-induced aromatase expression and estrogen biosynthesis in adipose stromal cells

The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.

P304

83-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TEM.2011.10.003

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51878571

http://www.w3.org/2001/XMLSchema#string

P698

22169755

http://www.w3.org/2001/XMLSchema#string

P921

P932

3428377

http://www.w3.org/2001/XMLSchema#string